Страна: Австралия
Язык: английский
Источник: Department of Health (Therapeutic Goods Administration)
piperacillin sodium, Quantity: 4170 mg (Equivalent: piperacillin, Qty 4000 mg); tazobactam sodium, Quantity: 536 mg (Equivalent: tazobactam, Qty 500 mg)
Omegapharm
piperacillin sodium,tazobactam sodium
Injection, powder for
Excipient Ingredients:
Intravenous
5 vials, 1 vial
(S4) Prescription Only Medicine
OMEGAPHARM PIPERACILLIN AND TAZOBACTAM is indicated for the treatment of serious bacterial infections caused by susceptible strains of beta-lactamase producing organisms in the following conditions, - lower respiratory tract infections, - urinary tract infections (complicated and uncomplicated), - intra-abdominal infections, - skin and skin structure infections, - bacterial septicaemia, and, - gynaecological infections. Children under the age of 12 years. In hospitalised children aged 2 to 12 years, OMEGAPHARM PIPERACILLIN AND TAZOBACTAM is indicated for the treatment of serious intra-abdominal infections. It has not been evaluated in this indication for paediatric patients below the age of 2 years. . While OMEGAPHARM PIPERACILLIN AND TAZOBACTAM is indicated only for the conditions listed above, it may be used as a single agent in the treatment of mixed infections caused by piperacillin susceptible and beta-lactamase producing, piperacillin resistant organisms. Appropriate culture and susceptibility tests sho
Visual Identification: White or off-white powder.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Registered
2011-09-08